GlassScriptPhysician profile
Matthew Schindler
NPI 1184949414
$11,397.28
in general payments reported to CMS, 2019-2025
7 companies · $4,267 in 2025
The $4,267 reported for 2025 was more than what 97% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $150 · 2021: $154 · 2022: $161 · 2023: $1,882 · 2024: $4,783 · 2025: $4,267.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,514 · Consulting Fee: $3,275 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,836 · Travel and Lodging: $681 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $625.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,514.47 |
| Consulting Fee | $3,275.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,836.00 |
| Travel and Lodging | $681.36 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $625.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $6,033.02 | 2022-2025 | |
| Emd Serono, INC. | $2,000.88 | 2022-2025 | |
| Tg Therapeutics, INC. | $1,180.37 | 2024-2025 | |
| Biogen, INC. | $940.31 | 2019-2025 | Tysabri, Vumerity, Tecfidera |
| Celgene Corporation | $924.34 | 2024 | Zeposia |
| Novartis Pharmaceuticals Corporation | $195.96 | 2024-2025 | |
| Alexion Pharmaceuticals, INC. | $122.40 | 2024 | Ultomiris |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Schindler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.